MUSCIANISI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 281
EU - Europa 261
AS - Asia 111
SA - Sud America 1
Totale 654
Nazione #
US - Stati Uniti d'America 280
IE - Irlanda 115
SE - Svezia 87
SG - Singapore 56
CN - Cina 49
IT - Italia 20
DE - Germania 16
FI - Finlandia 7
GB - Regno Unito 4
PL - Polonia 4
BE - Belgio 2
FR - Francia 2
HK - Hong Kong 2
HU - Ungheria 2
LT - Lituania 2
BO - Bolivia 1
CA - Canada 1
IN - India 1
IR - Iran 1
MY - Malesia 1
VN - Vietnam 1
Totale 654
Città #
Dublin 115
Chandler 73
Nyköping 44
Singapore 42
Ashburn 38
Princeton 16
Medford 12
Beijing 11
Dearborn 11
Des Moines 10
Munich 10
Boardman 8
Jinan 7
Jacksonville 6
Bremen 5
Helsinki 5
Los Angeles 5
Messina 5
Seattle 5
Cambridge 4
Zhengzhou 4
Hangzhou 3
Nanjing 3
Pachino 3
Washington 3
Brussels 2
Guangzhou 2
Hebei 2
Hong Kong 2
Houston 2
London 2
Ningbo 2
San Mateo 2
Sopron 2
Taizhou 2
Tianjin 2
Trezzo Sull'adda 2
Ann Arbor 1
Ardabil 1
Dalian 1
Fremont 1
Fuzhou 1
Hyderabad 1
La Paz 1
Leawood 1
Monmouth Junction 1
Nanning 1
Norwalk 1
Quanzhou 1
Riva 1
San Gregorio Di Catania 1
Shah Alam 1
Shenyang 1
Shijiazhuang 1
Taiyuan 1
Toronto 1
Urbino 1
Vittoria 1
Wilmington 1
Totale 494
Nome #
Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients 59
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 58
Real world use of antidiabetic drugs in the years 2011–2017: A population-based study from Southern Italy 57
Diagnostic accuracy of faecal calprotectin in a symptom-based algorithm for early diagnosis of inflammatory bowel disease adjusting for differential verification bias using a Bayesian approach 56
Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences 54
FRAGILITÀ E PROFILO LIPIDICO IN UN GRUPPO DI PAZIENTI ANZIANI OSPEDALIZZATI 52
Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study 50
Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences” 48
Frailty and lipid profile in a sample of elderly inpatients 46
Effectiveness of Ustekinumab on Crohn‘s Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 42
HDL subclasses and the common CETP TaqIB variant predict the incidence of microangiopatic complications in type 2 diabetic women: A 9 years follow-up study 36
null 33
null 28
Ustekinumab in Crohn's disease: Real-world outcomes from the Sicilian network for inflammatory bowel diseases 23
Predictors of Covid-19 vaccination acceptance in IBD patients: a prospective study 17
Fatigue, sarcopenia, and frailty in older adults with inflammatory bowel disease 11
Low Adherence is Associated with Chronic Active Disease in Ulcerative Colitis: A Retrospective Study from a Single Referral Center 9
A real world investigation on prevalence, clinical features, and therapy of inflammatory bowel disease in the city of Messina, Italy 8
Mitigating the Risk of Tofacitinib-induced Adverse Events in the Elderly Population with Ulcerative Colitis 7
Totale 694
Categoria #
all - tutte 4.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019 0 0 0 0 0 0 2 4 1 7 3 2
2020/202149 0 9 17 2 6 1 1 3 0 0 10 0
2021/2022113 0 11 0 2 2 1 13 1 3 39 4 37
2022/2023276 14 36 11 19 21 23 0 16 126 2 7 1
2023/202499 6 5 7 16 10 15 1 11 1 12 1 14
2024/2025103 5 18 5 23 27 25 0 0 0 0 0 0
Totale 694